AIP
ENFN

Ameritas Investment Partners’s Enfusion, Inc. ENFN Stock Holding History

Ameritas Investment Partners’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,960
Closed -$55.3K – 3389
2025
Q1 		$55.3K Hold
4,960
– – ﹤0.01% 2054
2024
Q4 		$51.1K Hold
4,960
– – ﹤0.01% 2166
2024
Q3 		$47.1K Buy
4,960
+1,177
+31% +$10.2K ﹤0.01% 2225
2024
Q2 		$32.2K Hold
3,783
– – ﹤0.01% 2379
2024
Q1 		$35K Hold
3,783
– – ﹤0.01% 2321
2023
Q4 		$36.7K Hold
3,783
– – ﹤0.01% 2319
2023
Q3 		$33.9K Buy
3,783
+2,101
+125% +$20K ﹤0.01% 2303
2023
Q2 		$18.9K Hold
1,682
– – ﹤0.01% 2595
2023
Q1 		$17.7K Hold
1,682
– – ﹤0.01% 2517
2022
Q4 		$20.3K Hold
1,682
– – ﹤0.01% 2560
2022
Q3 		$20K Hold
1,682
– – ﹤0.01% 2533
2022
Q2 		$17K Hold
1,682
– – ﹤0.01% 2640
2022
Q1 		$21K Hold
1,682
– – ﹤0.01% 2549
2021
Q4 		$35K Buy
+1,682
New +$34K ﹤0.01% 2358

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ameritas Investment Partners's ENFN Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 4,960 shares — an estimated $55.3K sold.

Ameritas Investment Partners first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $55.3K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 4,960 Enfusion, Inc. shares in Q2 2025, an estimated $55.3K.
  • Ameritas Investment Partners first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Ameritas Investment Partners's Enfusion, Inc. position peaked at $55.3K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.